Related Experiment Video
Updated: Jan 13, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
Mesoporous Silica: A Promising Adjuvant for Cancer Vaccines
1Health and Medical Research Institute, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
Abstract:
Cancer immunotherapy has revolutionized oncology by utilizing the body's immune system to fight cancer. Unlike traditional treatments such as surgery, chemotherapy, and radiotherapy, immunotherapy enhances the body's immune capacity, enabling it to target and eliminate cancer cells accurately. However, there are still challenges associated with immunotherapy, including limited efficacy, drug resistance, potential side effects, and difficulties in patient selection. Mesoporous silica (MS) particles have been investigated for enhancing cancer immunotherapy due to their advantageous structural features, excellent drug-delivery properties, and intrinsic immune-activation modulation capabilities. This review mainly focuses on the latest research progress of MS particle-based cancer vaccine adjuvants. First, we will give an overview of the progress in cancer immunotherapy. Second, we will introduce the applications of inorganic materials in cancer vaccines. Third, we will focus on the latest progress in the application of MS particles in cancer vaccine adjuvants. Finally, we conclude this review by outlining the challenges and future perspectives of MS particle-based cancer vaccine adjuvants.
More Related Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...